Estrogen therapy and liver function—metabolic effects of oral and parenteral administration

@article{Schoultz1989EstrogenTA,
  title={Estrogen therapy and liver function—metabolic effects of oral and parenteral administration},
  author={B. V. VON Schoultz and K. Carlstroem and L. Collste and A. Eriksson and P. Henriksson and A. Pousette and R. Stege},
  journal={The Prostate},
  year={1989},
  volume={14}
}
  • B. V. VON Schoultz, K. Carlstroem, +4 authors R. Stege
  • Published 1989
  • Medicine, Biology
  • The Prostate
    • Oral estrogen therapy for prostatic cancer is clinically effective but also accompanied by severe cardiovascular side effects. Hypertension, venous thromboembolism, and other cardiovascular disorders are associated with alterations in liver metabolism. The impact of exogenous estrogens on the liver is dependent on the route of administration and the type and dose of estrogen. Oral administration of synthetic estrogens has profound effects on liver‐derived plasma proteins, coagulation factors… CONTINUE READING
    View on Wiley
    ncbi.nlm.nih.gov
    76 Citations
    Highly Influencial Citations
    3
    Background Citations
    17
    Methods Citations
    1
    Results Citations
    1
    76 Citations
    Citation Type

    Citation Type

    androgen deprivation therapy for prostate cancer - the potential of parenteral estrogen
    Therapy Insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy
    • 32
    Estrogen in Patients with Prostatic Cancer
    • 4
    Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
    • 1
    • PDF
    Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer.
    • 4
    Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.
    • 64
    • PDF
    Side effects of endocrine treatment and their mechanisms: Castration, antiandrogens, and estrogens
    • 37
    Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer.
    • 12
    • PDF
    Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma.
    • 43
    A prodrug design for improved oral absorption and reduced hepatic interaction.
    • 1

    References

    SHOWING 1-10 OF 42 REFERENCES
    Steroid‐sensitive proteins, growth hormone and somatomedin C in prostatic cancer: Effects of parenteral and oral estrogen therapy
    • 31
    Enhanced hepatic extraction of estrogens used for replacement therapy.
    • 59
    A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy
    • 22
    Treatment of prostatic cancer: effects on serum lipoproteins and the cardiovascular system.
    • 19
    Efficacy of transdermal estradiol.
    • H. Judd
    • Medicine
    • American journal of obstetrics and gynecology
    • 1987
    • 63
    Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women.
    • 87
    A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy
    • 64
    Treatment of prostatic carcinoma with various types of estrogen derivatives.
    • 62
    Estrogen induction of liver proteins and high-density lipoprotein cholesterol: comparison between estradiol valerate and ethinyl estradiol.
    • 22
    High density lipoprotein subfractions during oral and cutaneous administration of 17 beta-estradiol to menopausal women.
    • 69